GOODWILL AND INTANGIBLE ASSETS (Note)

6 Months Ended

Jun. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

The balance of goodwill and intangible assets, net is as follows (in thousands):



	June 30, 2016			December 31, 2015
Goodwill	$	487,095		$	486,720
Accumulated impairment losses	(483,088		)	(483,088		)
Net goodwill	$	4,007		$	3,632

Intangible assets with indefinite lives	$	10,142		$	10,142
Intangible assets with definite lives, net	5,253			850
Total intangible assets, net	$	15,395		$	10,992

Goodwill and Indefinite-Lived Intangible Assets

The Company's goodwill is associated with its one reportable segment, Lending. Intangible assets with indefinite lives relate to the Company's trademarks.

Intangible Assets with Definite Lives

Intangible assets with definite lives relate to the following (in thousands):



	Cost		Accumulated Amortization			Net
Technology	$	400	$	(11	)	$	389
Customer lists	4,900		(233		)	4,667
Other	1,287		(1,090		)	197
Balance at June 30, 2016	$	6,587	$	(1,334	)	$	5,253



	Cost		Accumulated Amortization			Net
Customer lists	$	1,000	$	(150	)	$	850
Other	1,087		(1,087		)	—
Balance at December 31, 2015	$	2,087	$	(1,237	)	$	850

Amortization of intangible assets with definite lives is computed on a straight-line basis and, based on balances as of June 30, 2016, future amortization is estimated to be as follows (in thousands):



	Amortization Expense
Remainder of current year	$	332
Year ending December 31, 2017	664
Year ending December 31, 2018	664
Year ending December 31, 2019	586
Year ending December 31, 2020	530
Thereafter	2,477
Total intangible assets with definite lives, net	$	5,253

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details